Barclays
OPK icon

Barclays’s Opko Health OPK Stock Holding History

Barclays’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-39,400
Closed -$58K – 6370
2019
Q4 		$58K Hold
39,400
– – ﹤0.01% 5698
2019
Q3 		$82K Hold
39,400
– – ﹤0.01% 5622
2019
Q2 		$96K Hold
39,400
– – ﹤0.01% 5726
2019
Q1 		$103K Sell
39,400
-221,400
-85% -$670K ﹤0.01% 5339
2018
Q4 		$785K Sell
260,800
-50,800
-16% -$172K ﹤0.01% 3367
2018
Q3 		$1.08M Buy
311,600
+106,800
+52% +$567K ﹤0.01% 3545
2018
Q2 		$963K Sell
204,800
-2,100
-1% -$7.97K ﹤0.01% 3336
2018
Q1 		$656K Sell
206,900
-56,900
-22% -$229K ﹤0.01% 3675
2017
Q4 		$1.29M Sell
263,800
-126,200
-32% -$732K ﹤0.01% 2843
2017
Q3 		$2.67M Buy
390,000
+159,900
+69% +$1.01M ﹤0.01% 2067
2017
Q2 		$1.51M Buy
230,100
+174,800
+316% +$1.23M ﹤0.01% 2502
2017
Q1 		$442K Sell
55,300
-81,400
-60% -$685K ﹤0.01% 3522
2016
Q4 		$1.27M Buy
136,700
+19,200
+16% +$199K ﹤0.01% 2515
2016
Q3 		$1.24M Buy
117,500
+8,100
+7% +$80.7K ﹤0.01% 2425
2016
Q2 		$1.02M Sell
109,400
-134,000
-55% -$1.36M ﹤0.01% 2593
2016
Q1 		$2.43M Sell
243,400
-4,063,650
-94% -$37.1M ﹤0.01% 1746
2015
Q4 		$43.1M Buy
4,307,050
+1,750
+0% +$17.5K 0.05% 323
2015
Q3 		$34.4M Buy
4,305,300
+1,402,000
+48% +$18.6M 0.04% 381
2015
Q2 		$46.5M Sell
2,903,300
-752,400
-21% -$11.7M 0.05% 310
2015
Q1 		$51.2M Sell
3,655,700
-120,900
-3% -$1.57M 0.06% 318
2014
Q4 		$34M Buy
3,776,600
+1,623,100
+75% +$13.9M 0.03% 504
2014
Q3 		$17.2M Buy
2,153,500
+180,300
+9% +$1.58M 0.02% 813
2014
Q2 		$15.8M Buy
1,973,200
+73,600
+4% +$643K 0.02% 834
2014
Q1 		$17.1M Sell
1,899,600
-78,000
-4% -$684K 0.02% 791
2013
Q4 		$15.8M Sell
1,977,600
-238,500
-11% -$2.41M 0.02% 912
2013
Q3 		$17.7M Buy
2,216,100
+1,171,200
+112% +$9.39M 0.02% 738
2013
Q2 		$7.42M Buy
+1,044,900
New +$7.22M 0.01% 1312

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's OPK Position: Q1 2026 in Review

Barclays reduced its Opko Health (OPK) stake by 79% in Q1 2026, selling an estimated $646K and leaving 138,300 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.

Barclays first reported a position in OPK in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.4M in Q4 2015. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • Barclays held 138,300 shares of Opko Health worth $158K as of Q1 2026.
  • Barclays sold 524,936 Opko Health shares in Q1 2026, an estimated $646K.
  • Opko Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3826 holding.
  • Barclays first reported a position in Opko Health in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Opko Health position peaked at $19.4M in Q4 2015.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.